Twist Bioscience Corporation (TWST)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.78B |
| Enterprise Value | 1.56B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.70 |
| Price/Book (mrq) | 3.01 |
| Enterprise Value/Revenue | 5.94 |
| Enterprise Value/EBITDA | -9.04 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.62 |
| 52-Week Change 3 | 148.38% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 43.21 |
| 52 Week Low 3 | 11.46 |
| 50-Day Moving Average 3 | 35.00 |
| 200-Day Moving Average 3 | 27.52 |
Share Statistics
| Avg Vol (3 month) 3 | 895.13k |
| Avg Vol (10 day) 3 | 957.51k |
| Shares Outstanding 5 | 57.82M |
| Implied Shares Outstanding 6 | 57.82M |
| Float 8 | 56.94M |
| % Held by Insiders 1 | 1.78% |
| % Held by Institutions 1 | 112.61% |
| Shares Short (Apr 15, 2024) 4 | 12.25M |
| Short Ratio (Apr 15, 2024) 4 | 17 |
| Short % of Float (Apr 15, 2024) 4 | 27.79% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 21.19% |
| Shares Short (prior month Mar 15, 2024) 4 | 12.01M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 30, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -78.44% |
| Operating Margin (ttm) | -65.70% |
Management Effectiveness
| Return on Assets (ttm) | -15.87% |
| Return on Equity (ttm) | -30.80% |
Income Statement
| Revenue (ttm) | 262.36M |
| Revenue Per Share (ttm) | 4.59 |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -176.4M |
| Net Income Avi to Common (ttm) | -205.8M |
| Diluted EPS (ttm) | -3.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 311.14M |
| Total Cash Per Share (mrq) | 5.38 |
| Total Debt (mrq) | 91.88M |
| Total Debt/Equity (mrq) | 15.57% |
| Current Ratio (mrq) | 5.98 |
| Book Value Per Share (mrq) | 10.21 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111.38M |
| Levered Free Cash Flow (ttm) | -67.14M |
© 2024 Yahoo. All rights reserved.